Back
Speaker illustration

Doctor Minako Kagimoto

Yokohama city university hospital, Yokohama (Japan)

Presentations

Plasma lysoGb3 useful as biomarker in screening for Fabry disease in patients with mild left ventricular hypertrophy

Event: ESC Congress 2018

Topic: Infiltrative Myocardial Disease

Session: Cardiomyopathy in Fabry disease

Access
Like
Thumbnail

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources